A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
NCT ID: NCT02517554
Last Updated: 2024-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2015-08-31
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
NCT05427240
Methods for Increasing Genetic Testing Uptake in Michigan
NCT05162846
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
NCT02917798
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
NCT05420064
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
NCT04902144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remote cancer genetic services by videoconference
Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site
Baseline and follow up survey
Remote cancer genetic services by telephone
Penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site
Baseline and follow up surveys
Usual Care
Patient receives written information on how to find genetic services in their area
Baseline and follow up surveys
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site
Baseline and follow up survey
Penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site
Baseline and follow up surveys
Patient receives written information on how to find genetic services in their area
Baseline and follow up surveys
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian or colorectal cancers
3. have insurance coverage for genetic testing.
Exclusion Criteria
2. Does not speak English.
3. Does not have insurance.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abramson Cancer Center at Penn Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angela Bradbury, MD
Role: PRINCIPAL_INVESTIGATOR
Abramson Cancer Center at Penn Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Union Hospital
Elkton, Maryland, United States
Cape Regional Medical Center
Cape May Court House, New Jersey, United States
Kennedy Health
Sewell, New Jersey, United States
Shore Cancer Center
Somers Point, New Jersey, United States
Gettysburg Cancer Center
Gettysburg, Pennsylvania, United States
Drexel Cancer Care at Hahnemann
Philadelphia, Pennsylvania, United States
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UPCC 09115
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.